A sharp decline in its Medicare Star Ratings for 2025 has prompted Humana (NYSE:HUM) to file a lawsuit in a Texas federal ...

Humana faces significant challenges with rising denial rates and customer disenrollment, leading to a sharp decline in stock ...

Bloomberg News Now is a comprehensive audio report on today's top stories. Listen for the latest news, whenever you want it, covering global business stories around the world.

U.S. health insurer Cigna Group has revived efforts to merge with smaller rival Humana after abandoning the pursuit late last ...

周二，RBC Capital调整了Humana（纽约证券交易所代码：HUM）的股价目标，将其从之前的400美元下调至265美元。该公司维持了对这家医疗保健公司的"跑赢大市"评级。此次调整是在Humana上周在8-K文件中披露的基于初步Medicare Advantage（MA）表现数据的星级评级下降之后做出的。 RBC Capital引入了对Humana 2026年调整后每股收益（EPS）的预估， ...

Cigna has brought merger talks with Humana back from the dead, according to a new report in Bloomberg.

近期，美国健康保险公司Cigna重新启动了与Humana的合并谈判，双方正在进行初步讨论以探讨潜在的交易可能性。这次讨论是在Cigna去年年底因收购价格分歧而暂停收购Humana的努力之后展开的。 消息公布后，Humana的股价在周五盘后交易中上涨约5%，而Cigna的股价下跌约4%。此前，Cigna放弃了谈判尝试，转而宣布了一项价值100亿美元的股票回购计划。 今年早些时候，Cigna以33亿美 ...

Humana recently reached a $90 million settlement with the United States to resolve allegations that Humana submitted ...

伯恩斯坦：将Humana的评级从“与大市同步”上调至“跑赢大市”，并将目标价从405美元下调至308美元。

Cigna's stock was down 5% to $318.98 in after-hours trading Friday. Shares ended the regular session down 4.8% at $336, but are up 12% this year. At the same time, shares of Humana gained 5.6% to $283 ...

The stock market was up in the third quarter, but many stocks still took it on the chin, including Occidental Petroleum and ...

生物科技公司Cigna将恢复与Humana合并的磋商。 生物科技公司Cigna将恢复与Humana合并的磋商。